These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 9893961)

  • 41. Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody.
    Foulon CF; Reist CJ; Bigner DD; Zalutsky MR
    Cancer Res; 2000 Aug; 60(16):4453-60. PubMed ID: 10969792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
    Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA
    Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.
    Grill J; Van Beusechem VW; Van Der Valk P; Dirven CM; Leonhart A; Pherai DS; Haisma HJ; Pinedo HM; Curiel DT; Gerritsen WR
    Clin Cancer Res; 2001 Mar; 7(3):641-50. PubMed ID: 11297260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
    Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
    Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
    Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.
    Shir A; Ogris M; Wagner E; Levitzki A
    PLoS Med; 2006 Jan; 3(1):e6. PubMed ID: 16318410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells.
    Steck PA; Gallick GE; Maxwell SA; Kloetzer WS; Arlinghaus RB; Moser RP; Gutterman JU; Yung WK
    J Cell Biochem; 1986; 32(1):1-10. PubMed ID: 3533968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
    Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
    Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225.
    Ye D; Mendelsohn J; Fan Z
    Oncogene; 1999 Jan; 18(3):731-8. PubMed ID: 9989823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal antibody radiopharmaceuticals: cationization, pegylation, radiometal chelation, pharmacokinetics, and tumor imaging.
    Lee HJ; Pardridge WM
    Bioconjug Chem; 2003; 14(3):546-53. PubMed ID: 12757378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.
    Yang W; Barth RF; Wu G; Kawabata S; Sferra TJ; Bandyopadhyaya AK; Tjarks W; Ferketich AK; Moeschberger ML; Binns PJ; Riley KJ; Coderre JA; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
    Clin Cancer Res; 2006 Jun; 12(12):3792-802. PubMed ID: 16778107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
    Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
    J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier.
    Hui EK; Boado RJ; Pardridge WM
    Mol Pharm; 2009; 6(5):1536-43. PubMed ID: 19624167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier.
    Qiao R; Jia Q; Hüwel S; Xia R; Liu T; Gao F; Galla HJ; Gao M
    ACS Nano; 2012 Apr; 6(4):3304-10. PubMed ID: 22443607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.
    Wu D; Yang J; Pardridge WM
    J Clin Invest; 1997 Oct; 100(7):1804-12. PubMed ID: 9312181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo cleavability of a disulfide-based chimeric opioid peptide in rat brain.
    Bickel U; Kang YS; Pardridge WM
    Bioconjug Chem; 1995; 6(2):211-8. PubMed ID: 7599264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain.
    Cooke MJ; Wang Y; Morshead CM; Shoichet MS
    Biomaterials; 2011 Aug; 32(24):5688-97. PubMed ID: 21550655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.